Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in ...

The U.S. Department of Health and Human Services (HHS), through the Centers for Medicare & Medicaid Services (CMS), has ...

The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Abe Sutton, a health policy aide in the first Trump administration, is likely to be named head of the Center for Medicare and ...

The blockbuster diabetes and weight-loss drug semaglutide (Ozempic, Rybelsus, Wegovy) along with therapies for asthma, ...

Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...

Xavier Becerra is reflecting on tenure as HHS secretary. He told Scripps News, "We're leaving this country is healthier and ...

President-elect Donald Trump's HHS appointees represent a broad spectrum of healthcare perspectives and are poised to significantly influence public health, pharmaceuticals and health systems.   With ...

A new Health and Human Services report is calling for greater transparency in long-term care ownership, calling out private ...